参考文献/References:
[1] KREUZER M. Cancer risk from low-dose ionizingradiation[J]. Der Radiologe, 2017, 57(7): 517-518.
[2] KEIL A P, RICHARDSON D B. Quantifying cancerrisk from radiation[J]. Risk Analysis, 2018, 38(7):1474-1489.
[3] MISHRA S , YADAV T, RANI V. ExploringmiRNA based approaches in cancer diagnosticsand therapeutics[J]. Critical Reviews in OncologyHematology, 2016, 98: 12-23.
[4] 芦嘉, 史伟峰. 血清miRNA-720 和miRNA-484 在结肠癌分期及早期诊断中的应用[J]. 现代检验医学杂志, 2017,32(1):77-79,83.LU Jia,SHI Weifeng. Application of serum miRNA-720and miRNA-484 in the staging and early diagnosisof colon cancer[J]. Journal of Modern LaboratoryMedicine, 2017,32(1):77-79,83.
[5] SCHMITTGEN T D, LIVAK K J. Analyzing real-timePCR data by the comparative CT method[J]. NatureProtocols, 2008, 3(6): 1101-1108.
[6] SCHMITTGEN T D, LEE E J, JIANG Jinmai. Highthroughputreal-time PCR[J]. Methods in MolecularBiology (Clifton, N.J.), 2008, 429: 89-98.
[7] International Atomic Energy Agency. Cytogenetic dosimetry:Applications in preparedness for and responseto radiation emergencies[R].Vienna:IAEA,2011.
[8] 林仲武, 王琪, 王治东. 辐射生物剂量计的研究现状及发展方向[J]. 中华放射医学与防护杂志,2017,37(10):799-804.LIN Zhongwu,WANG Qi,WANG Zhidong. Overviewof current situation and future development of radiationbiodosimetry study [J]. Chinese Journal of RadiologicalMedicine and Protection, 2017,37(10):799-803.
[9] GARTY G, TURNER H C, SALERNO A, et al.The decade of the RABIT (2005-15)[J]. RadiationProtection Dosimetry, 2016, 172(1/3): 201-206.
[10] REPIN M, PAMPOU S, KARAN C, et al. RABITII:implementation of a high-throughput micronucleusbiodosimetry assay on commercial biotech roboticsystems[J]. Radiation Research, 2017, 187(4): 492-498.
[11] LU T X, ROTHENBERG M E. MicroRNA[J]. TheJournal of Allergy and Clinical Immunology, 2018,141(4): 1202-1207.
[12] ZHENG Mengyue, HOU Ling, MA Yu, et al. Exosomallet-7d-3p and miR-30d-5p as diagnostic biomarkersfor non-invasive screening of cervical cancer and itsprecursors[J]. Molecular Cancer, 2019, 18(1): 76.
[13] 赵格, 高琼, 余宗涛, 等. 肺癌患者血浆miR-3151表达水平与临床病理特征的相关性研究[J]. 现代检验医学杂志,2020,35(5):28-32.ZHAO Ge,GAO Qiong,YU Zongtao,et al. Study onthe correlation between the expression of miR-3151in plasma and clinicopathological features in patientswith lung cancer[J]. Journal of Modern LaboratoryMedicine, 2020, 35 (5):28- 32.
[14] 张筱东, 谢星星, 李佳, 等. 血清外泌体miR-221 和miR-378 水平检测在胃癌诊断中的应用研究[J]. 现代检验医学杂志, 2020, 35(6):52-55.ZHANG Xiaodong,XIE Xingxing,LI Jia,et al.Application study of serum exosome miR-221 andmiR-378 detection in the diagnosis of gastric cancer[J]. Journal of Modern Laboratory Medicine, 2020,35(6):52-55.
[15] BACKES C, MEESE E, KELLER A. Specific miRNAdisease biomarkers in blood, serum and plasma:challenges and prospects[J]. Molecular Diagnosis &Therapy, 2016, 20(6): 509-518.
[16] WANG Lin,ZHANG Lijuan. Circulating microRNAsas diagnostic biomarkers for motor neuron disease[J].Frontiers in Neuroscience, 2020, 14: 00354.
[17] 李刚强, 濮亚斌, 王寅. 小剂量辐射致小鼠血液中microRNA 表达改变[J]. 实用预防医学,2016,23(4):405-408.LI Gangqiang,PU Yabin,WANG Yin. MicroRNAexpression changes induced by low-dose irradiation inmice[J]. Practical Preventive Medicine, 2016, 23 (4):405- 408.
[18] 于海月,葛常辉,冯宝民.miRNA 调控辐射损伤相关信号通路研究[J].中国生物化学与分子生物学报,2020,36(6):634-639.YU Haiyue,GE Changhui,FENG Baomin. Researchon the related signaling pathways for radiation damageregulation by miRNA [J]. Chinese Journal of Biochemistryand Molecular Biology,2020,36(6):634-639.
[19] SONG Man, XIE Dafei, GAO Shanshan, et al. Abiomarker panel of radiation-upregulated miRNAas signature for ionizing radiation exposure[J]. Life(Basel), 2020, 10(12): 361.
[20] 侯殿俊, 马娅, 李洁清, 等. 电离辐射诱发人外周血miRNA-150 表达水平的改变及意义[J]. 中国辐射卫生, 2019,28(6):606-608,613.HOU Dianjun,MA Ya,LI Jieqing,et al. Ionizingr a d iat i o n induced miRNA-150 changes inperipheral blood[J]. Chinese Journal of RadiologicalHealth,2019,28(6):606-608,613.